Why Previous Regimens Change the Conversation
Chemotherapy uses drugs to kill or slow the growth of cancer cells, and treatment schedules differ according to the prescribed regimen. That single sentence explains why a Chinese oncology team cannot give you a meaningful opinion from a diagnosis alone. The prior regimen is part of the clinical history: it shows what was already tried, how the disease responded, and which side effects limited treatment. Without it, any discussion about a next step is speculative.
This matters most when you are deciding whether to seek care in China at all. If your question is about continuing an existing regimen, the team needs to know whether the same drugs, doses and schedule are available and appropriate. If your question is about changing to a new regimen, the team needs to understand why the previous one stopped. The reason could be disease progression, unacceptable toxicity, completion of planned cycles, or a patient preference. Each reason leads to a different clinical question.
A common mistake is to send only the latest scan report or a brief diagnosis letter. That is not enough for a chemotherapy review. The receiving clinician needs the treatment history in a form that can be checked against the original records. Ask your current oncology team for a regimen summary that lists each drug, the dose, the number of cycles given, the dates, the best response, and the reason for stopping or pausing. If that summary does not exist, request it before you travel or before you ask for a remote opinion.
The Records That Make a Previous Regimen Review Possible
A useful chemotherapy record set is more specific than a general medical file. For each prior line of treatment, the oncology team will want the regimen name or drug names, the dose and route, the planned schedule, the actual dates of each cycle, and any dose reductions or delays. They will also want the response assessment: imaging reports, tumour marker trends if they were used, and the clinical impression recorded by your treating team. Toxicity matters too. Neuropathy, low blood counts, infection, kidney or liver changes, and allergic reactions can all affect what a future team considers.
Pathology and staging records remain relevant because chemotherapy is chosen in the context of the cancer type, subtype and stage. If your cancer has a molecular marker that guides treatment, the test report should be included. If you have had surgery or radiotherapy, the dates and reports help the new team understand the sequence of care. Do not assume that a discharge summary covers everything. Ask whether the original pathology report, the operative note and the imaging discs are available.
Language is a practical issue. If your records are not in Chinese or English, ask the hospital or your coordination contact what translation or interpretation is needed before the review. A translated summary can help, but the treating team may still want the original documents. Ask what format they accept for imaging: discs, cloud links or printed films. These are administrative questions, not clinical decisions, and they are worth settling early.
New Regimen or Ongoing Treatment: Ask Which Question Is Being Answered
Before a hospital reviews your case, clarify the purpose of the review in writing. Are you asking whether a new regimen is appropriate, or whether an ongoing regimen can be continued in China? These are different questions with different information needs. A new-regimen question usually requires a fresh assessment of disease status, prior lines of therapy, organ function and available options. An ongoing-treatment question requires confirmation that the same drugs and schedule can be delivered, and that monitoring can be arranged.
This distinction affects what you should ask the hospital. For a new regimen, ask what additional tests or imaging the oncology team would need before deciding, and whether those tests can be done locally or in China. For ongoing treatment, ask whether the hospital can continue the exact regimen, what documentation it needs from your current prescriber, and how it would handle cycle timing if you travel. Do not assume that continuation is automatically possible. Drug availability, formulary rules and clinical judgement all belong to the treating hospital.
It also affects your own planning. If the question is a new regimen, you may need a period of assessment before treatment starts. If the question is continuation, the timing of your travel may need to align with your current cycle. Neither situation should be managed by delaying necessary local care. If your current clinician has advised urgent treatment, that advice takes priority over an overseas enquiry.
Cycle Planning and Monitoring: What to Confirm With the Treating Team
Chemotherapy is delivered in cycles, and the schedule is specific to the regimen. The treating team decides the interval, the dose and any modifications. If you are considering care in China, ask how the hospital would coordinate cycles with your previous treatment. Would there be a gap between your last cycle and the first cycle in China? What monitoring is required before each cycle, and where would it be done? Who reviews the blood tests, and how quickly would a dose change be communicated?
Monitoring is not a formality. Blood counts, liver and kidney function, and symptom review are part of safe chemotherapy delivery. Ask the hospital what its process is for reviewing results and for contacting you if a cycle needs to be delayed or modified. Ask what happens if you develop a fever or another urgent symptom between cycles, and which local facility you should contact. These questions are about the hospital's own arrangements, so ask the named provider rather than relying on general assumptions.
If you are planning to travel, ask how many cycles the hospital would expect you to receive in China and how that fits with your overall treatment plan. Do not ask for a guaranteed number of cycles or a fixed timeline; the treating team must decide based on your response and tolerance. What you can ask is how the hospital usually structures a treatment plan for an international patient and what it needs from you to make that plan. A written reply is more useful than a verbal estimate.
Questions That Belong to the Oncology Team, Not the Coordinator
A coordination service can help you organise records, arrange an appointment and interpret practical instructions. It cannot decide whether a regimen is suitable, whether a dose should change, or whether you should stop or continue a medicine. Those decisions belong to licensed clinicians who have reviewed your records and, where necessary, examined you. When you send an enquiry, separate the administrative questions from the clinical ones. Administrative questions include what documents to send, how to share imaging, and what language support is available. Clinical questions include whether a new regimen is appropriate and what monitoring is needed.
It is reasonable to ask a clinician about evidence-based risk estimates and the uncertainty around them. It is not reasonable to expect a remote reviewer to guarantee an outcome or to confirm hospital acceptance before your records have been assessed. A records-based opinion can clarify options and identify missing information, but it does not replace an in-person assessment or establish final eligibility for treatment. If a hospital offers you an appointment, that is a step in the process, not a promise that a particular regimen will be given.
You should also ask what the review covers. Is it a general opinion on your history, or a specific plan for treatment in China? If you want a plan, ask what the hospital needs to produce one and what its limitations are. A clear answer to that question helps you decide whether to travel, what to prepare, and what to ask your current team before you go.
Preparing Your Enquiry and the Next Practical Step
Start with a short summary rather than a complete archive. State the diagnosis, the previous regimens with dates, the reason each stopped, and your main question. Then ask what additional records the hospital needs. This keeps the first exchange manageable and lets the receiving team tell you what matters most. If you have imaging, ask how it should be shared. If you have a current prescriber, ask whether a letter from that clinician would help.
ChinaSpecialistCare can help you organise this enquiry and coordinate an appointment with a suitable hospital or specialist team after the hospital accepts your case. The free initial case review checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. It is not a diagnosis or a promise of acceptance. A proxy consultation is optional and not a prerequisite for every appointment.
The practical next step is to write down your previous regimens in a simple table, gather the supporting reports, and send a brief summary through the enquiry form, email or WhatsApp. Ask the hospital what it needs for a chemotherapy review and whether your question is about a new regimen or ongoing treatment. Keep your current clinician informed, and do not delay urgent local care while you prepare an overseas enquiry. For more on how chemotherapy planning is approached, see the related chemotherapy planning page.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.